137 related articles for article (PubMed ID: 24561682)
1. False-positive uptake of 124I in a laryngeal cyst mimicking thyroid remnant after thyroidectomy and 131i therapy for follicular thyroid carcinoma.
Noordman BJ; Comans E; Lips P; Rinkel RN
Clin Nucl Med; 2014 Oct; 39(10):898-9. PubMed ID: 24561682
[TBL] [Abstract][Full Text] [Related]
2. Nasoalveolar cyst as a cause of false positive result in post-therapy 131I whole body scintigraphy.
García-Talavera P; Ruiz MÁ; Montes AA; Gamazo C; González ML; Olmos R
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):288-9. PubMed ID: 23067534
[No Abstract] [Full Text] [Related]
3. False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
Schmidt M; Dietlein M; Schröder U; Schicha H
Clin Nucl Med; 2006 Nov; 31(11):716-7. PubMed ID: 17053394
[TBL] [Abstract][Full Text] [Related]
4. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.
Leboulleux S; Schroeder PR; Busaidy NL; Auperin A; Corone C; Jacene HA; Ewertz ME; Bournaud C; Wahl RL; Sherman SI; Ladenson PW; Schlumberger M
J Clin Endocrinol Metab; 2009 Apr; 94(4):1310-6. PubMed ID: 19158200
[TBL] [Abstract][Full Text] [Related]
6. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
[TBL] [Abstract][Full Text] [Related]
7. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
Mirallié E; Guillan T; Bridji B; Resche I; Rousseau C; Ansquer C; Bodet-Milin C; Curtet C; Carnaille B; Murat A; Charbonnel B; Kraeber-Bodéré F
Surgery; 2007 Dec; 142(6):952-8; discussion 952-8. PubMed ID: 18063081
[TBL] [Abstract][Full Text] [Related]
9. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
10. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
11. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on
Wang F; Nie H; Li W; Zhang R; Li W
BMC Med Imaging; 2021 May; 21(1):78. PubMed ID: 33964885
[TBL] [Abstract][Full Text] [Related]
13. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
14. 131I uptake in intraosseous hemangioma of the skull: mimicking a bone metastasis in thyroid cancer.
Lee M; Lee YK; Jeon TJ; Park CS; Ryu YH
Clin Nucl Med; 2014 Nov; 39(11):990-2. PubMed ID: 24978336
[TBL] [Abstract][Full Text] [Related]
15. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK
J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
[TBL] [Abstract][Full Text] [Related]
16. Pre-therapy hyperfunctioning follicular thyroid carcinoma evaluation with I-131 whole-body scan and with F-18 FDG PET/CT.
Orsolon P; Giachetti M; Lupi A; Salgarello M; Malfatti V; Zanco P
Clin Nucl Med; 2008 Dec; 33(12):882-6. PubMed ID: 19033798
[TBL] [Abstract][Full Text] [Related]
17. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
18. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
[TBL] [Abstract][Full Text] [Related]
19. Anthracofibrosis Manifesting as False-Positive Iodine Accumulation in a Patient With Recent History of Thyroid Carcinoma.
Licht K; Kroegel C; Katenkamp K; Freesmeyer M
Clin Nucl Med; 2016 Apr; 41(4):336-7. PubMed ID: 26571446
[TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]